Price Alert

Leap Therapeutics Inc. (LPTX)

NASDAQ: LPTX · Real-Time Price · USD

0.53

-0.20 (-27.40%)

At close: Oct 03, 2025, 3:59 PM

0.57

6.09%

After-hours: Oct 03, 2025, 07:56 PM EDT

-27.40% (1D)

Bid	0.53
Market Cap	22.11M
Revenue (ttm)	10K
Net Income (ttm)	-65.69M
EPS (ttm)	-1.83
PE Ratio (ttm)	-0.29
Forward PE	-1.38
Analyst	n/a
Dividends	n/a

Ask	0.54
Volume	6,904,128
Avg. Volume (20D)	1,397,946
Open	0.73
Previous Close	0.73
Day's Range	0.46 - 0.80
52-Week Range	0.22 - 4.79
Beta	-0.06
Ex-Dividend Date	n/a

About LPTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol LPTX

Website n/a

Full Company Profile

Why Price Moved

1 month ago

-28.14%

Leap Therapeutics shares are trading lower after t... Unlock content with Pro Subscription

6 months ago

+16.88%

Leap Therapeutics shares are trading higher after the company presented updated preliminary data from its Sirexatamab colorectal cancer study.

News

6 months ago · seekingalpha.com

Leap Therapeutics (LPTX) Conference Call to discuss Updated Data from Part B of the DeFianCe Study Transcript

Leap Therapeutics (NASDAQ:LPTX ) Conference Call to discuss Updated Data from Part B of the DeFianCe Study March 26, 2025 8:00 AM ET Company Participants Douglas Onsi - President and CEO Cyndi Sirard ...

6 months ago · benzinga.com

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

Leap Therapeutics, Inc. LPTX presented updated preliminary data on Wednesday from Part B of the DeFianCe Phase 2 trial of sirexatamab (DKN-01) in combination with bevacizumab and chemotherapy (Experi...